Viemed Healthcare (VMD) EV to EBITDA (2019 - 2026)

Viemed Healthcare (VMD) has reported EV to EBITDA for 8 consecutive years, with 95.37 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBITDA rose 90.15% year-over-year to 95.37; the trailing twelve-month figure through Jun 2026 stood at 18.69 (up 53.67% YoY), and the FY2025 full-year result was 11.81, down 29.13% from the prior year.
• EV to EBITDA improved to 95.37 in Q2 2026 per VMD's latest filing, from 80.79 in the prior quarter.
• Across five years, EV to EBITDA topped out at 162.76 in Q1 2024 and bottomed at 24.45 in Q3 2023.
• Historically, EV to EBITDA has averaged 56.53 across 5 years, with a median of 47.62 in 2024.
• The sharpest annual moves came in 2022 and 2024: EV to EBITDA sank 68.55% in 2022, then surged 214.8% in 2024.
• Over 5 years, EV to EBITDA stood at 34.24 in 2022, then jumped by 59.82% to 54.72 in 2023, then declined by 15.54% to 46.22 in 2024, then dropped by 29.97% to 32.37 in 2025, then soared by 194.65% to 95.37 in 2026.
• According to Business Quant data, EV to EBITDA over the past three periods registered 95.37, 80.79, and 32.37 for Q2 2026, Q1 2026, and Q4 2025 respectively.